Loading…
We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Head-to-head evidence comparison — which supplement is right for you?
Citicoline and Huperzine A are closely matched across evidence, studies, and safety.
Verdict
Probably helps
3 of 5 studies with measurable effects showed benefit.
Top outcomes
Verdict
Likely helps
4 of 5 studies with measurable effects showed benefit.
Top outcomes
Shared outcomes (2)
Outcomes where both Citicoline and Huperzine A have evidence — compare verdict strength side-by-side.
250-500mg daily
Morning for daytime cognitive enhancement
Cognizin® branded citicoline
50-200mcg twice daily
Morning and early afternoon, Avoid evening (may cause vivid dreams)
Huperzine A capsules (standardized extract)
1-4 weeks
4-8 weeks
1-2 weeks
2-4 weeks
30-60 minutes
2-4 weeks
During use
Is Citicoline Effective in Preventing and Slowing Down Dementia?-A Systematic Review and a Meta-Analysis
Nutrients (2023) · Meta analysis
Overall, citicoline improved cognitive status, with pooled standardized mean differences ranging from 0.56 (95% CI: 0.37-0.75) to 1.57 (95% CI: 0.77-2.37) in different sensitivity analyses.
Application of Citicoline in Neurological Disorders: A Systematic Review
Nutrients (2020) · Systematic review
In an animal model of nerve damage and neuropathy, citicoline stimulated regeneration and lessened pain.
Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly
Cochrane Database of Systematic Reviews (2005) · Systematic review
Positive effects on memory
The treatment of cognitive dysfunction in dementia: a multiple treatments meta-analysis
Psychopharmacology (2018) · Meta analysis · n=44854
The pooled standardized mean difference of the treatment effects on cognitive dysfunction was 0.439 (95% confidence interval 0.374, 0.504).
Traditional Chinese herbal medicine for vascular dementia
The Cochrane database of systematic reviews (2018) · Systematic review · n=3581
Two TCHMs (NaoMaiTai and TongXinLuo) had a 5% or more increased risk of AEs compared to the 'no Treatment' control, but the quality of this evidence was poor.
Interventions to delay functional decline in people with dementia: a systematic review of systematic reviews
BMJ open (2016) · Systematic review · n=289
The quality of the reviews varied; however most (65%) scored 8/11 or more on the AMSTAR tool, indicating high quality.
Based on meta-analysis showing SMD 0.56-1.57 for cognitive status improvement. Conservative estimates due to heterogeneity across studies and varying populations (stroke, dementia, TBI). Effect sizes modest and studies show mixed quality levels.
Based on meta-analysis showing MMSE improvement (WMD: 2.27) in dementia populations. Evidence primarily from dementia patients, limited data in healthy individuals. Quality concerns noted in systematic reviews regarding study methodology.
AI-estimated from published studies. Interpret as directional guidance.
Both Citicoline and Huperzine A are closely matched — the best choice depends on your specific health goals.
For sharpen focus, Citicoline has a higher relevance score (88 vs 80).
No known interactions between Citicoline and Huperzine A have been documented in our database. However, always consult a healthcare provider before combining supplements.